Navigation Links
Surgery Viable for Advanced Prostate Cancer, Study Finds
Date:5/17/2011

TUESDAY, May 17 (HealthDay News) -- Surgery to remove the prostate gland (radical prostatectomy) led to a 20-year survival rate for 80 percent of patients with advanced prostate cancer, a new study finds.

The study included patients with cancer that had spread beyond the prostate, known as cT3 prostate cancer, and underwent radical prostatectomy between 1987 and 1997.

The 80 percent survival rate in these patients compares to a 90 percent survival rate at 20 years for patients with cancer confined to the prostate (cT2 prostate cancer), the Mayo Clinic researchers said.

Previously, patients with cT3 prostate cancer were offered radiation or hormone treatment, but not radical prostatectomy, the study authors noted in a Mayo news release.

"We are doing a much better job of identifying and expanding candidates for surgery, which results in better, longer outcomes for so many of our patients," Dr. R. Jeffrey Karnes, of the department of urology, said in the news release.

The study was slated for presentation May 15 at the annual meeting of the American Urological Association, in Washington, D.C. Research presented at meetings is considered preliminary until it is published in a peer-reviewed journal.

More information

The American Cancer Society has more about prostate cancer.

-- Robert Preidt

SOURCE: Mayo Clinic, news release, May 15, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Obese People at Higher Risk of Infection After Colon Surgery
2. Advanced-stage prostate cancer patients experience 20-year survival rates with surgery
3. Brain Surgery for Mary Tyler Moore to Remove Benign Tumor
4. Synthetic mesh can improve outcome of prolapse surgery
5. Vaginal Mesh Surgery Effective for Bladder Prolapse Repair: Report
6. Weight-Loss Surgery Seems No Riskier for Seniors
7. Stem cell technology used in unique surgery
8. Surgery May Beat Antibiotics for Appendicitis, Study Finds
9. Surgery reduces risk of mortality due to prostate cancer even for low-risk groups
10. Heart Bypass Surgery Rates Drop Dramatically, Study Finds
11. Low-dose chest CT effective in reducing radiation for evaluation of cardiothoracic surgery patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Surgery Viable for Advanced Prostate Cancer, Study Finds
(Date:7/20/2017)... Valencia, Calif. (PRWEB) , ... July 19, 2017 , ... ... has acquired the Minnesota based Health IT business unit of Constellation Inc., a move ... an already established base of operations in St. Louis, the acquisition is expected to ...
(Date:7/20/2017)... California (PRWEB) , ... July 19, 2017 , ... A ... that most successful weight loss surgery patients who had received a body contouring procedure ... health and beauty clinic Beverly Hills Physicians (BHP), which provides both types of procedures, ...
(Date:7/20/2017)... ... ... “Lucky the Buffalo and Her Adventures”: a collection of heartwarming children’s stories. “Lucky the ... Bieniek Jr. was born in Toledo, Ohio. He attended Woodward High School. He ... married to a brilliant woman with a caring heart named Tiina, who is a hospice ...
(Date:7/18/2017)... ... July 18, 2017 , ... ClinicalTrials.gov and the ... You Need to Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — 1:30 p.m. ... “Final Rule for Clinical Trials Registration and Results Information,” is a head-scratcher. After ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Anacortes, ... "Due to menopause, I have frequent hot flashes, and I suffer from anxiety and ... way to keep cool while out and about." INSTA-FAN meets that need. , This ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Corp., also known as ,The Epigenetics Company, announced today the release of ... using the myDNAge ™ test. Based on Horvath,s Clock, so named ... biostatistics at the David Geffen School of Medicine at UCLA ... ™ technology is used to analyze DNA methylation patterns of over ... Epigenetic ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... TRIANGLE PARK, N.C. , July 10, 2017 /PRNewswire/ ... a $5m Convertible Note to support the development of ... by Tencent Holdings Limited, a leading Chinese Internet services ... This funding will advance multiple infectious disease product programs ... Founded by Dr. ...
Breaking Medicine Technology: